Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11719395rdf:typepubmed:Citationlld:pubmed
pubmed-article:11719395lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0013902lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0015295lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0017958lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:11719395lifeskim:mentionsumls-concept:C0030375lld:lifeskim
pubmed-article:11719395pubmed:issue12lld:pubmed
pubmed-article:11719395pubmed:dateCreated2001-11-23lld:pubmed
pubmed-article:11719395pubmed:abstractTextErythrocyte polymorphisms, including ovalocytosis, have been associated with protection against malaria. This study in the Wosera, a malaria holoendemic region of Papua New Guinea, examined the genetic basis of ovalocytosis and its influence on susceptibility to malaria infection. Whereas previous studies showed significant associations between Southeast Asian ovalocytosis (caused by a 27- base pair deletion in the anion exchanger 1 protein gene) and protection from cerebral malaria, this mutation was observed in only 1 of 1019 individuals in the Wosera. Polymerase chain reaction strategies were developed to genotype individuals for the glycophorin C exon 3 deletion associated with Melanesian Gerbich negativity (GPCDeltaex3). This polymorphism was commonly observed in the study population (GPCDeltaex3 frequency = 0.465, n = 742). Although GPCDeltaex3 was significantly associated with increased ovalocytosis, it was not associated with differences in either Plasmodium falciparum or P vivax infection measured over the 7-month study period. Future case-control studies will determine if GPCDeltaex3 reduces susceptibility to malaria morbidity.lld:pubmed
pubmed-article:11719395pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11719395pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11719395pubmed:languageenglld:pubmed
pubmed-article:11719395pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11719395pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11719395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11719395pubmed:statusMEDLINElld:pubmed
pubmed-article:11719395pubmed:monthDeclld:pubmed
pubmed-article:11719395pubmed:issn0006-4971lld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:KazuraJ WJWlld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:PatelS SSSlld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:MgoneC SCSlld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:ZimmermanP...lld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:MehlotraR KRKlld:pubmed
pubmed-article:11719395pubmed:authorpubmed-author:KastensWWlld:pubmed
pubmed-article:11719395pubmed:issnTypePrintlld:pubmed
pubmed-article:11719395pubmed:day1lld:pubmed
pubmed-article:11719395pubmed:volume98lld:pubmed
pubmed-article:11719395pubmed:ownerNLMlld:pubmed
pubmed-article:11719395pubmed:authorsCompleteYlld:pubmed
pubmed-article:11719395pubmed:pagination3489-91lld:pubmed
pubmed-article:11719395pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:meshHeadingpubmed-meshheading:11719395...lld:pubmed
pubmed-article:11719395pubmed:year2001lld:pubmed
pubmed-article:11719395pubmed:articleTitleThe association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea.lld:pubmed
pubmed-article:11719395pubmed:affiliationDivision of Geographic Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. ssp6@po.cwru.edulld:pubmed
pubmed-article:11719395pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11719395pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11719395lld:pubmed